We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+11.85%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.64%
AUM
$1.44B
AUM Growth
+$68.4M
Cap. Flow
-$66.6M
Cap. Flow %
-4.63%
Top 10 Hldgs %
32.08%
Holding
123
New
8
Increased
28
Reduced
49
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 25.09%
2 Healthcare 23.99%
3 Industrials 13.95%
4 Materials 7.8%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LOPE icon
26
Grand Canyon Education
LOPE
$3.93B
$29.7M 2.07%
636,565
-24,651
-4% -$1.1M
EGOV
27
DELISTED
NIC Inc
EGOV
$29.4M 2.05%
1,634,739
-37,024
-2% -$660K
MLAB icon
28
Mesa Laboratories
MLAB
$566M
$27.1M 1.88%
350,322
+7,646
+2% +$560K
MTDR icon
29
Matador Resources
MTDR
$6.06B
$24.6M 1.71%
1,218,072
-29,692
-2% -$616K
ROL icon
30
Rollins
ROL
$18.2B
$24.1M 1.67%
2,453,807
-53,447
-2% -$499K
MDSO
31
DELISTED
Medidata Solutions, Inc.
MDSO
$23.9M 1.67%
501,411
-10,112
-2% -$438K
RGEN icon
32
Repligen
RGEN
$8.45B
$22.4M 1.56%
1,133,493
-21,901
-2% -$490K
HIBB
33
DELISTED
Hibbett, Inc. Common Stock
HIBB
$19.8M 1.38%
408,793
-31,167
-7% -$1.45M
SQI
34
DELISTED
SCIQUEST, INC. COMMON STOCK
SQI
$19.1M 1.33%
1,319,649
-96,438
-7% -$1.45M
NVEC icon
35
NVE Corp
NVEC
$618M
$19M 1.32%
268,061
-12,547
-4% -$869K
SSYS icon
36
Stratasys
SSYS
$764M
$17.8M 1.24%
213,861
-9,955
-4% -$1.02M
LGND icon
37
Ligand Pharmaceuticals
LGND
$6.03B
$17.6M 1.22%
529,096
+59,326
+13% +$1.93M
MCF
38
DELISTED
Contango Oil & Gas Co.
MCF
$16.4M 1.14%
559,206
-123,351
-18% -$4.15M
TECH icon
39
Bio-Techne
TECH
$11.2B
$15.4M 1.07%
668,380
-23,788
-3% -$544K
HCSG icon
40
Healthcare Services Group
HCSG
$1.59B
$15M 1.04%
483,614
-4,821
-1% -$143K
ABAX
41
DELISTED
Abaxis Inc
ABAX
$14.3M 1%
251,934
-323,047
-56% -$17.3M
NRCIB
42
DELISTED
National Research Corp Class B
NRCIB
$14.1M 0.98%
391,810
-4,302
-1% -$149K
EXA
43
DELISTED
EXA Corporation
EXA
$13.9M 0.97%
1,185,849
-11,098
-0.9% -$121K
NRC icon
44
NRC Health Common Stock
NRC
$434M
$13.3M 0.93%
954,056
-24,484
-3% -$360K
VASC
45
DELISTED
Vascular Solutions Inc
VASC
$12.6M 0.88%
465,230
+340,428
+273% +$9.24M
MORN icon
46
Morningstar
MORN
$7.51B
$11.8M 0.82%
181,626
-8,701
-5% -$576K
ACTG icon
47
Acacia Research
ACTG
$445M
$8.36M 0.58%
493,744
-257,427
-34% -$4.46M
PFIE
48
DELISTED
Profire Energy, Inc
PFIE
$4.24M 0.3%
1,861,226
-19,849
-1% -$63.9K
UFI icon
49
UNIFI
UFI
$126M
$2.11M 0.15%
70,905
XOM icon
50
ExxonMobil
XOM
$638B
$1.91M 0.13%
20,680

Similar funds

Conestoga Capital Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Conestoga Capital Advisors held 123 positions worth $1.44B, up 5% from $1.37B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Conestoga Capital Advisors withdrew a net $66.6M in Q4 2014, closing 5 positions and reducing 49 holdings. Its most notable exit was Geospace Technologies, an estimated $21.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Conestoga Capital Advisors opened a new position in iShares Russell 2000 Growth ETF worth $1.61M.

  • Conestoga Capital Advisors's largest Q4 2014 buy was iShares Russell 2000 Growth ETF: 11,305 shares worth $1.61M.
  • Conestoga Capital Advisors added most to Vascular Solutions Inc in Q4 2014, an estimated $9.24M increase.
  • Conestoga Capital Advisors's biggest Q4 2014 reduction was Abaxis Inc, cutting an estimated $17.3M.
  • Conestoga Capital Advisors fully exited Geospace Technologies in Q4 2014, selling an estimated $21.4M.
  • Conestoga Capital Advisors's ten largest holdings make up 32% of its $1.44B portfolio in Q4 2014.
  • Conestoga Capital Advisors opened 8 new positions and closed 5 in Q4 2014.
  • Conestoga Capital Advisors's portfolio value rose 5% quarter-over-quarter to $1.44B.

Based on Conestoga Capital Advisors's 13F filing for Q4 2014, filed 12 Jan 2015.